These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 25459783)

  • 1. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
    Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
    BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
    Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
    Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).
    Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B
    Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive prenatal testing.
    Lo JO; Cori D F; Norton ME; Caughey AB
    Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance and indications of noninvasive prenatal testing using cell free circulating fetal DNA (cffDNA) for the detection of fetal trisomy 21, 18 and 13 in France].
    Benachi A; Letourneau A; Kleinfinger P; Senat MV; Gautier E; Favre R; Bidat L; Houfflin-Debarge V; Querol V; Bouyer J; Costa JM;
    J Gynecol Obstet Biol Reprod (Paris); 2016 Jun; 45(6):633-40. PubMed ID: 26518155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex.
    Koumbaris G; Kypri E; Tsangaras K; Achilleos A; Mina P; Neofytou M; Velissariou V; Christopoulou G; Kallikas I; González-Liñán A; Benusiene E; Latos-Bielenska A; Marek P; Santana A; Nagy N; Széll M; Laudanski P; Papageorgiou EA; Ioannides M; Patsalis PC
    Clin Chem; 2016 Jun; 62(6):848-55. PubMed ID: 27117469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of determining the limit of detection of non-invasive prenatal testing methods.
    Fiorentino F; Bono S; Pizzuti F; Mariano M; Polverari A; Duca S; Sessa M; Baldi M; Diano L; Spinella F
    Prenat Diagn; 2016 Apr; 36(4):304-11. PubMed ID: 26815144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
    Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
    Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.